Several hedge funds and institutional investors have recently adjusted their investments in Becton, Dickinson and Company (BDX). Jennison Associates LLC increased its stake by 4.9%, now holding 402,350 shares worth $99.56 million after buying 18,786 additional shares. Norden Group LLC saw a massive 2,086.7% increase in its stake, owning 51,934 shares now valued at $12.85 million after adding 49,559 shares. Franklin Street Advisors NC bought a new position worth about $11.99 million. Avity Investment Management Inc. raised its stake by 3.5%, owning 162,687 shares worth $40.26 million after purchasing 5,527 shares. Caden Capital Partners LP increased its stake by 26.7%, holding 83,417 shares valued at $20.34 million after adding 17,599 shares. Institutional investors currently own 86.97% of BDX stock.
Analyst Ratings
Analysts have recently updated their ratings for BDX. Evercore ISI raised its price target from $286 to $290 with an outperform rating. StockNews.com upgraded BDX from hold to buy. Stifel Nicolaus increased its price target from $270 to $280, maintaining a buy rating. Raymond James lowered its target from $275 to $270 while keeping an outperform rating. Citigroup upgraded BDX from neutral to buy, raising the target from $255 to $275. Overall, Becton, Dickinson and Company has a consensus rating of Buy with an average price target of $282.63.
Price Performance
Becton, Dickinson and Companys stock (NYSE:BDX) opened at $239.76. Key financial ratios include a quick ratio of 1.36, a current ratio of 1.85, and a debt-to-equity ratio of 0.70. The market cap stands at $69.29 billion, with a P/E ratio of 52.81. It has a 52-week low of $218.75 and a high of $269.52. The stock’s fifty-day moving average is $236.55.
The latest quarterly earnings report showed an EPS of $3.50, beating estimates by $0.19. Revenue for the quarter was $4.99 billion, slightly below estimates. BDX’s quarterly revenue rose by 2.3% from the previous year.
Dividends
Becton, Dickinson and Company recently paid a quarterly dividend of $0.95 per share on September 30, with a 1.58% yield. The annual dividend amounts to $3.80, representing a payout ratio of 83.70%.
Becton, Dickinson and Company Overview
Becton, Dickinson and Company develops and sells medical supplies and devices for healthcare applications globally, divided into three segments: BD Medical, BD Life Sciences, and BD Interventional.
Related Articles
- Five stocks we prefer over BDX
- Overview of the Shanghai Stock Exchange Composite Index
- S&P 500 Resistance: Top 3 Stocks to Consider
- Natural Gas Prices Rise: Beneficial Stocks to Watch
- Nikes Earnings Dip: A Possible Buying Opportunity
- Using the Russell 2000 Index for Profitable Trades
- Microsofts Promising Upside Might Be Unmissable
Subscribe for Daily Becton, Dickinson and Company News – Enter your email below for a summary of the latest news and ratings:
